Pharmaron Beijing Co., Ltd.
300759
Classement en actions
#2354
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a... Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Prix de l'action
$5.58
Capitalisation boursière
$8.24B
Changement (1 jour)
-3.77%
Changement (1 an)
28.36%
Pays
CN
Échange Pharmaron Beijing Co., Ltd. (300759)
Catégorie
Healthcare
EPS pour Pharmaron Beijing Co., Ltd. (300759)
EPS au June 2026 TTM : $0.15
Selon les derniers rapports financiers et le cours de l'action de Pharmaron Beijing Co., Ltd., l’EPS actuel de la société (TTM) est de $0.15. À la fin de 2024, la société avait un EPS de $0.14 une augmentation par rapport à celui de 2023, qui était de $0.13.
Historique de l'EPS de Pharmaron Beijing Co., Ltd. de 2014 à 2026
EPS à la fin de chaque année
| Année | EPS | Changez |
|---|---|---|
| 2026 (TTM) | $0.15 | 11.77% |
| 2025 | $0.13 | -2.89% |
| 2024 | $0.14 | 8.89% |
| 2023 | $0.13 | 12.38% |
| 2022 | $0.11 | -65.77% |
| 2021 | $0.33 | 45.81% |
| 2020 | $0.23 | 90.10% |
| 2019 | $0.12 | 115.94% |
| 2018 | $0.06 | 38.00% |
| 2017 | $0.04 | 20.85% |
| 2016 | $0.03 | -14.03% |
| 2015 | $0.04 | 474.63% |
| 2014 | $0.01 | 0.00% |
EPS pour des entreprises ou concurrents similaires
| Entreprise | EPS | Différence d’EPS | Pays |
|---|---|---|---|
| $17.32 | 11,820.17% |
US
|
|
| $-7.98 | -5,592.09% |
US
|
|
| $-5.29 | -3,740.74% |
AU
|
|
| $13.70 | 9,328.84% |
BE
|
|
| $27.74 | 18,991.53% |
NL
|
